| Mrs Rosafe Agbulos Valencia, RN | |
|
1721 Philadelphia Ave, Whiting, NJ 08759-2628 | |
| (732) 350-4056 | |
| Not Available |
| Full Name | Mrs Rosafe Agbulos Valencia |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Ambulatory Care |
| Location | 1721 Philadelphia Ave, Whiting, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336110733 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WP2201X | Registered Nurse - Ambulatory Care | NO57298 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Rosafe Agbulos Valencia, RN 1721 Philadelphia Ave., Whiting,, NJ 08759 Ph: (732) 350-4056 | Mrs Rosafe Agbulos Valencia, RN 1721 Philadelphia Ave, Whiting, NJ 08759-2628 Ph: (732) 350-4056 |
News Archive
In a new study scientists have reported that Sildenafil or Viagra pills used for erectile dysfunction could lead to longer lasting visual disturbances than known before. The study titled, "Ocular Side Effects of Sildenafil That Persist Beyond 24 h—A Case Series," was published in the latest issue of the journal Frontiers in Neurology.
Riki Ellison, Founder and Chairman of the Youth Impact Program announced on Friday, March 4th, 2011 that Tulane University, New Orleans Saints, SMART Technologies and the President's Council on Fitness, Sports on Nutrition are sponsoring the Youth Impact Program this July on the campus of Tulane University.
Agilent Technologies Inc. (NYSE:A) has chosen the Cambridge Health Institute's Next-Generation Sequencing Analysis conference today to introduce its SureSelect Human All Exon Kit for target enrichment prior to next-generation DNA sequencing.
A post-marketing safety study mandated by the U.S. Food and Drug Administration has shown that a combination drug therapy for the treatment of asthma is safe and effective.
› Verified 7 days ago